💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Philips sees 4-6 percent sales growth in health technology push

Published 11/02/2017, 07:44 AM
Updated 11/02/2017, 07:50 AM
© Reuters.  Philips sees 4-6 percent sales growth in health technology push

AMSTERDAM (Reuters) - Philips expects sales to grow by 4 to 6 percent in the coming three years as it focuses on growth in the health technology market, the Dutch company said on Thursday.

Philips spun off its lighting division last year to focus on medical devices and healthcare products. Its main divisions now sell personal health products, such as electrical toothbrushes, and hospital equipment, including high-end medical scanners and imaging tools.

Ahead of its capital markets day on Thursday, Philips said it expected the total market for health technology to grow to almost 200 billion euros ($233 billion) in 2020 from 149 billion euros now.

The company, which made 17 billion euros in sales from health technology in 2016, reiterated its sales goal for the coming three years, as well as the promise of an annual average improvement of its operational profit margin by 100 basis points.

Meanwhile, its free cash flow is expected to amount to 1-1.5 billion euros each year.

Earlier this month, the company said its sales had grown by 4 percent in the first nine months of 2017, with the adjusted core profit (EBITA) margin improving to 12.8 percent in the third quarter.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.